Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
URLC10 peptide vaccine in advanced NSCLC
NCT01949701Phase 2Completed
- Sponsor
- Shiga University
- Start
- Aug 2011
- Primary completion
- Mar 2019
- Modality
- Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of URLC10 in non-small cell lung cancer (NSCLC), sponsored by Shiga University. Started Aug 2011; status: completed.
02
Drugs
URLC10
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01949701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01949701.